March 25, 2019
WELLESLEY, Mass., March 25, 2019— A new report from BCC Research, “Medical Membrane Devices: Markets and Technologies” estimates that by 2023, the global market for medical membrane devices will reach $36.5 billion, up from $28.6 billion in 2018, indicating a compound annual growth rate (CAGR) of 5%.
Medical membrane devices are integral to modern healthcare. They have become indispensable tools in the diagnostic market, and are sold to hospitals, clinics, blood-handling facilities, physicians, nursing homes and pharmacies, as well as to home users or home-treated patients.
Top leaders in the medical membrane devices market include: Baxter International (BAX), Fresenius Medical Care (FMS), B. Braun Medical and NxStage Medical.
Report Highlights
“Medical membrane devices have evolved tremendously in the past few years, but they still face tough competition in the broader healthcare marketplace,” said BCC Research analyst Andrew McWilliams. “New technologies and techniques are coming on the market, bringing alternatives that are both more advanced and cost effective.”
Editors/reporters requesting analyst interviews should contact Eric Surber at press@bccresearch.com.
Medical Membrane Devices: Markets and Technologies( MST043G )
Publish Date: Mar 2019
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.